Dr. Anatoly Zhitkovich-Expert Evaluator at the Integrated Risk Information System (IRIS) Program Public Science Meeting on 1/11/23

Dr. Anatoly Zhitkovich served as the National Academy of Sciences (NAS) selected expert to evaluate EPA's Plan to conduct Integrated Risk Information System (IRIS)  Assessment of Inhalation Exposure to Cobalt and Cobalt Compounds. The EPA held a public meeting on this topic on 1-11-23 where Dr. Zhitkovich gave two presentations. The first presentation was on the "Association Between Lung and Adrenal Tumor Formation" and the second was on "Proposed MOA of Cobalt Carcinogenicity."

Cancer Drug Resistance Interview with Dr. Wafik El-Deiry

On December 1, 2022, the Editorial Office of Cancer Drug Resistance (CDR) was very honored to interview Journal Editorial Board member Prof. Wafik S. El-Deiry, who is Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, Director of the Cancer Center at Brown University, and Director of the Joint Program in Cancer Biology at Brown University and Affiliated Hospitals, Providence, RI, USA.

In the interview, Prof. El-Deiry shared what motivated him to enter the field of oncology research, research advances, and challenges in the field. In addition, he shared that the original discovery of p21 is one of the most exciting things in his career. p21 was the first mammalian CDK inhibitor to be discovered, which eventually led to the discovery and development of a new class of now FDA approved CDK inhibitor drugs. Furthermore, he also gave some advice to young researchers. He stressed that young researchers should really consider pursuing oncology research when they do have some interest and skills on it. He said that they can really make a difference in the world. Finally, he talked about how cancer drug resistance is very important and has huge challenges, and hoped that we could continue making important progress.

View the complete interview at the link below:

CDR Interview with Dr. El-Deiry

 

 

 

 

 

News from Women & Infants Hospital

1. Geralyn Messerlian, PhD, Professor of Pathology and Laboratory Medicine, CNE
Director of Clinical Chemistry and Special Testing, is appointed Vice Chair for Clinical
Faculty Development of the Department of Pathology of Warren Alpert Medical School
of Brown University effective August 10, 2022.
2. C. James Sung, MD, led an international team of College of American Pathologists
(CAP) inspectors conducted a virtual CAP inspection of the Department of Laboratory
Medicine of the First Hospital of China Medical University in Shenyang, Liaoning, China
on August 23-24, 2022.
3. The Microbiology Lab welcomes Amy Arruda, MLS(ASCP) as our new Microbiology
Lab Manager. Amy started 8/22/22. She joined us from the Beth Israel Deaconess
Plymouth Hospital.
4. The Department welcomes Steffanie C. Tamayo, MD, as our Visiting International
Fellow in Women’s Pathology. Dr. Tamayo joins us from the St. Luke’s Hospital in
Manila, Philippines. She will be with us until June 30, 2023.
5. Zhenwei Zhang, MDPhD, currently a pathology resident at the University of
Massachusetts, Worcester, is selected as the next Stuart Lauchlan Fellow in Gynecologic
Pathology and Breast Pathology in 2024-2025

Diana Treaba, MD - Director of Pathology Residency Program

Please join me in congratulating Dr. Abigail Alexander on being awarded for the second time in a row, the American Academy of Neuropathologists (AANP)Trainee Travel Award for her research entitled "Cortical-sparing Chronic Traumatic Encephalopathy (CS-CTE): Categorizing a Distinct Pathological Subtype of CTE" at the 98th Annual Meeting in Bonita Springs Florida.  This is a prestigious award which brings high honor to our department on a national level.

Pages